Paige Montanaro
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Paige Montanaro has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Alejandro Benjamin Balazs
Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA
1 shared publication - Alexander D. Klose
InVivo Analytics Inc., New York, NY 10023, USA
1 shared publication - Alexander J. Trachtenberg
Department of Microbiology, Boston University School of Medicine
1 shared publication - Alexander Ploss
Department of Molecular Biology, Princeton University
1 shared publication Amira Sheikh
Department of Microbiology, Boston University School of Medicine
1 shared publication- Andrew Emili
Donnelly Centre, University of Toronto , Toronto, ON M5S 3E1
1 shared publication
Latest Publications
- Open Access
Macrophages govern antiviral responses in human lung tissues protected from SARS-CoV-2 infection
The majority of SARS-CoV-2 infections among healthy individuals result in asymptomatic to mild disease. However, the immunological mechanisms defining effective lung tissue protection from SARS-CoV-2 infection remain elusive. Unlike mice solely engrafted with human fetal lung xenograft (fLX), mice co-engrafted with fLX and a myeloid-enhanced human immune system (HNFL mice) are protected against SARS-CoV-2 infection, severe inflammation, and histopathology. Effective control of viral infection in HNFL mice associated with significant macrophage infiltration, and the induction of a potent macrophage-mediated interferon response. The pronounced upregulation of the USP18-ISG15 axis (a negative regulator of IFN responses), by macrophages was unique to HNFL mice and represented a prominent correlate of reduced inflammation and histopathology. Altogether, our work shed light on unique cellular and molecular correlates of lung tissue protection during SARS-CoV-2 infection, and underscores macrophage IFN responses as prime targets for developing immunotherapies against coronavirus respiratory diseases. HIGHLIGHTS Mice engrafted with human fetal lung xenografts (fLX-mice) are highly susceptible to SARS-CoV-2. Co-engraftment with a human myeloid-enriched immune system protected fLX-mice against infection. Tissue protection was defined by a potent and well-balanced antiviral response mediated by infiltrating macrophages. Protective IFN response was dominated by the upregulation of the USP18-ISG15 axis.
Open AccessMacrophages govern antiviral responses in human lung tissues protected from SARS-CoV-2 infection
The majority of SARS-CoV-2 infections among healthy individuals result in asymptomatic to mild disease. However, the immunological mechanisms defining effective lung tissue protection from SARS-CoV-2 infection remain elusive. Unlike mice solely engrafted with human fetal lung xenograft (fLX), mice co-engrafted with fLX and a myeloid-enhanced human immune system (HNFL mice) are protected against SARS-CoV-2 infection, severe inflammation, and histopathology. Effective control of viral infection in HNFL mice associated with significant macrophage infiltration, and the induction of a potent macrophage-mediated interferon response. The pronounced upregulation of the USP18-ISG15 axis (a negative regulator of IFN responses), by macrophages was unique to HNFL mice and represented a prominent correlate of reduced inflammation and histopathology. Altogether, our work shed light on unique cellular and molecular correlates of lung tissue protection during SARS-CoV-2 infection, and underscores macrophage IFN responses as prime targets for developing immunotherapies against coronavirus respiratory diseases. HIGHLIGHTS Mice engrafted with human fetal lung xenografts (fLX-mice) are highly susceptible to SARS-CoV-2. Co-engraftment with a human myeloid-enriched immune system protected fLX-mice against infection. Tissue protection was defined by a potent and well-balanced antiviral response mediated by infiltrating macrophages. Protective IFN response was dominated by the upregulation of the USP18-ISG15 axis.